A nonsynonymous mutation in <em>PLCG<sub>2</sub></em><sub></sub> reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
- Publication date
- 1 January 2019
- Publisher
- Springer Verlag